Arcadia Investment Management Corp Bristol Myers Squibb CO Transaction History
Arcadia Investment Management Corp
- $584 Million
- Q2 2024
A detailed history of Arcadia Investment Management Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Arcadia Investment Management Corp holds 24,571 shares of BMY stock, worth $1.33 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
24,571
Previous 8,491
189.38%
Holding current value
$1.33 Million
Previous $460,000
121.74%
% of portfolio
0.17%
Previous 0.08%
Shares
18 transactions
Others Institutions Holding BMY
# of Institutions
2,404Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$10.1 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.6 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.95 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.04 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.2 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...